Cargando…
Synergistic Effects of Metformin and Trastuzumab on HER2 Positive Gastroesophageal Adenocarcinoma Cells In Vitro and In Vivo
SIMPLE SUMMARY: Metformin is widely used to treat type 2 diabetes with minimal side effects. Trastuzumab (Tmab) in combination with chemotherapy has been the standard treatment for HER2+ gastric cancer (GC) for the last two decades. Unfortunately, the use of subsequent HER2 targeted agents have not...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571931/ https://www.ncbi.nlm.nih.gov/pubmed/37835462 http://dx.doi.org/10.3390/cancers15194768 |